Phase II trial of pegylated-liposomal doxorubicin (Doxil™) in sarcoma

Research output: Contribution to journalArticlepeer-review

110 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of pegylated-liposomal doxorubicin (Doxil™) in sarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences